Paper37550801
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E and 41 others. J Pathol, 2023. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. Papers, record 37550801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37550801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sialyltransferases | Major topic |
| Prostatic Neoplasms | Major topic |
| Male | |
| Humans | |
| Glycosylation | |
| Polysaccharides | |
| United Kingdom | |
| beta-D-Galactoside alpha 2-6-Sialyltransferase | |
| Antigens, CD |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Department of Health | United Kingdom | PubMed |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42714773 | Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate. | Eur Radiol Exp | 2026 | https://conductscience.org/library/papers/42714773 | PubMed |
| 42647183 | Sulfonylurea Bioisosteres of Sulfonic Acid in JFD 00458-Based ST6GAL1 Inhibitors Enhance Membrane Permeability. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42647183 | PubMed |
| 42645226 | ST6GAL1 Is a Functional Regulator of UVA-Induced Photoaging in Human Dermal Fibroblasts. | Cells | 2026 | https://conductscience.org/library/papers/42645226 | PubMed |
| 42642385 | Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42642385 | PubMed |
| 42541248 | Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics. | Genes Dis | 2026 | https://conductscience.org/library/papers/42541248 | PubMed |
| 42443559 | Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42443559 | PubMed |
| 42373231 | Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 Overexpression Abrogates ST6GAL1 Mediated Rectal Cancer Chemoradiation Resistance. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/42373231 | PubMed |
| 42315913 | The glycobiology of prostate cancer: an update. | Oncogene | 2026 | https://conductscience.org/library/papers/42315913 | PubMed |
| 42291429 | N-glycosylation alterations in expressed prostatic secretions: exploring liquid biopsy biomarkers for prostate cancer diagnosis and disease progression. | PeerJ | 2026 | https://conductscience.org/library/papers/42291429 | PubMed |
| 42132142 | Tissue-specific factors that govern the sialoglycan-Siglec axis in cancer. | Biosci Rep | 2026 | https://conductscience.org/library/papers/42132142 | PubMed |
| 41737773 | Machine Learning-Based Sialylation-Associated Gene Signature Predicts Prognosis and Immune Landscape in Hepatocellular Carcinoma: Validation via Multi-Omics Analysis and in vitro Assays. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/41737773 | PubMed |
| 41718984 | Golgi Drivers of Cancer. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/41718984 | PubMed |
| 41651427 | Sialic acids modulate immune responses in cancer: Therapeutic opportunities. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651427 | PubMed |
| 41651416 | Writers and readers of sialylation in immunoregulation in cancer. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651416 | PubMed |
| 41584035 | Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. | J Cancer | 2026 | https://conductscience.org/library/papers/41584035 | PubMed |
| 41241472 | Spatial atlasing of N-glycosylation in healthy control and clear cell renal cell carcinoma tissues linked with immune checkpoint inhibition response by MALDI mass spectrometry imaging. | Anal Chim Acta | 2025 | https://conductscience.org/library/papers/41241472 | PubMed |
| 41228299 | Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228299 | PubMed |
| 41224336 | The relationship of ST6GAL1 with clinicopathological and prognostic factors in breast carcinomas. | Saudi Med J | 2025 | https://conductscience.org/library/papers/41224336 | PubMed |
| 41217711 | ST6GAL1-mediated sialylation inhibits the antitumor immune response in colorectal cancer. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/41217711 | PubMed |
| 41154604 | Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154604 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPHA2 | 170589 | PubTator's text mining | https://conductscience.org/library/genes/170589 | NCBI Gene |
| IGKV3D-25 | 28873 | PubTator's text mining | https://conductscience.org/library/genes/28873 | NCBI Gene |
| IGKV6-21 | 28906 | PubTator's text mining | https://conductscience.org/library/genes/28906 | NCBI Gene |
| ST6GAL1 | 6480 | PubTator's text mining | https://conductscience.org/library/genes/6480 | NCBI Gene |
| ST6GAL2 | 84620 | PubTator's text mining | https://conductscience.org/library/genes/84620 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37550801
GET https://conductscience.org/api/papers/v1/37550801/authors?page=2